12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers HTG Molecular Diagnostics (NASDAQ:HTGM) stock moved upwards by 170.4% to $1.46 during Monday’s pre-market session. The market…
5 Value Stocks In The Healthcare Sector
The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices…
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 402 companies made new 52-week lows.
Aptevo Therapeutics: Q2 Earnings Insights
Aptevo Therapeutics (NASDAQ:APVO) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
91 Biggest Movers From Friday
Gainers
RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Aptevo Therapeutics Announces New Preliminary Remission Data On Four Additional Patients Enrolled In On-going APVO436 Dose Expansion Phase 1B Trial For The Treatment Of Acute Myeloid Leukemia
Cohort 1 Combination Therapy Arm Shows 36% Remission Rate Among Response-evaluable Patients Treated to Date
Cohort 3 Monotherapy Patient Achieved Bone Marrow Complete Remission
Company Also Reports Myelodysplastic
Aptevo Therapeutics Granted U.S. Patent Titled ‘CD3 BINDING POLYPEPTIDES’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=11352426&OS=11352426&RS=11352426
Piper Sandler Maintains Overweight on Aptevo Therapeutics, Lowers Price Target to $20
Piper Sandler analyst Edward Tenthoff maintains Aptevo Therapeutics (NASDAQ:APVO) with a Overweight and lowers the price target from $69 to $20.
